* The spectra for all solutions displayed a peak at around 520 nm, which indicates the presence of GNPs. The general trend was that the absorbance of these peaks increased as the mole ratio of Au:HRP increases. This implies that the amount of GNPs in solution increased in accordance with the amount of gold initially added to each solution.

* The spectra for all solutions displayed a peak at around 520 nm, which indicates the presence of GNPs. The general trend was that the absorbance of these peaks increased as the mole ratio of Au:HRP increases. This implies that the amount of GNPs in solution increased in accordance with the amount of gold initially added to each solution.

* However, the peak absorbances for the 130 and 140 AuHRP solutions were almost identical. This is likely because the 130 AuHRP solution contained 1 mL less of H<sub>2</sub>O due to an error during preparation of the solution.

* However, the peak absorbances for the 130 and 140 AuHRP solutions were almost identical. This is likely because the 130 AuHRP solution contained 1 mL less of H<sub>2</sub>O due to an error during preparation of the solution.

+

<br><br>

[[Image:UV-Vis_Spectra_of_AuADA.JPG]]

[[Image:UV-Vis_Spectra_of_AuADA.JPG]]

+

* The spectra for all solutions did not display any significant peaks, which indicated that GNPs were not formed. This was corroborated by visual examination of the solutions, as described above.

+

* It was suggested that the [[User:Melissa_Novy/Notebook/CHEM-571/2012/09/26|elution buffer]] from [[User:Melissa_Novy/Notebook/CHEM-571/2012/11/06|FPLC]] in which the ADA was suspended interfered with the formation of GNPs. Consequently, the protocol was repeated with dialyzed ADA, as described below.

==Synthesizing AuADA Solutions==

==Synthesizing AuADA Solutions==

* Please refer to the protocol on [[User:Melissa_Novy/Notebook/CHEM-571/2012/11/14|2012/11/14]]. There were no deviations from the protocol and the same stock solution of HAuCl<sub>4</sub> was used. However, dialyzed ADA was used instead of ADA in FPLC elution buffer.

* Please refer to the protocol on [[User:Melissa_Novy/Notebook/CHEM-571/2012/11/14|2012/11/14]]. There were no deviations from the protocol and the same stock solution of HAuCl<sub>4</sub> was used. However, dialyzed ADA was used instead of ADA in FPLC elution buffer.

* Please refer to [[User:Keyun_Wang/Notebook/Experimental_Biological_Chemistry_I/2012/11/27|Keyun Wang's entry]] for observations made during the procedure.

* Please refer to [[User:Keyun_Wang/Notebook/Experimental_Biological_Chemistry_I/2012/11/27|Keyun Wang's entry]] for observations made during the procedure.

+

+

==Resuspension of AuHRP Fibers in Tris Buffer==

+

* Based on visual observation, it was determined that the 130, 140, and 150 AuHRP solutions contained the most fiber and were used for fiber resuspension.

+

* Please refer to [[User:Keyun_Wang/Notebook/Experimental_Biological_Chemistry_I/2012/11/27|Keyun Wang's entry]] for the protocol and concentrations and volumes of Tris buffer used. After Tris buffer was added to the three AuHRP solutions, the solutions were left to sit for 24 hours before being [[User:Melissa_Novy/Notebook/CHEM-571/2012/11/28|analyzed]].

Objectives

Please refer to Keyun Wang's entry for the procedure used to remove the ADA from the dialysis tubing and prepare it for use in AuADA solutions.

Resuspend AuHRP fibers in Tris buffer.

UV-Vis on AuHRP and AuADA

Exactly 3 mL of each solution was pipetted into a quartz cuvette for analysis using an automated pipetter (Pipetman).

Please refer to Dhea Patel's entry for photographs of the solutions.

Observations:

Small pellets of fibers were visible in all AuHRP solutions except 60 AuHRP. The 60 AuHRP solution did not contain a fiber pellet. All AuHRP solutions were purple in color.

AuADA solutions were colorless and contained no aggregates.

The spectra for all solutions displayed a peak at around 520 nm, which indicates the presence of GNPs. The general trend was that the absorbance of these peaks increased as the mole ratio of Au:HRP increases. This implies that the amount of GNPs in solution increased in accordance with the amount of gold initially added to each solution.

However, the peak absorbances for the 130 and 140 AuHRP solutions were almost identical. This is likely because the 130 AuHRP solution contained 1 mL less of H2O due to an error during preparation of the solution.

The spectra for all solutions did not display any significant peaks, which indicated that GNPs were not formed. This was corroborated by visual examination of the solutions, as described above.

It was suggested that the elution buffer from FPLC in which the ADA was suspended interfered with the formation of GNPs. Consequently, the protocol was repeated with dialyzed ADA, as described below.

Synthesizing AuADA Solutions

Please refer to the protocol on 2012/11/14. There were no deviations from the protocol and the same stock solution of HAuCl4 was used. However, dialyzed ADA was used instead of ADA in FPLC elution buffer.

Resuspension of AuHRP Fibers in Tris Buffer

Based on visual observation, it was determined that the 130, 140, and 150 AuHRP solutions contained the most fiber and were used for fiber resuspension.

Please refer to Keyun Wang's entry for the protocol and concentrations and volumes of Tris buffer used. After Tris buffer was added to the three AuHRP solutions, the solutions were left to sit for 24 hours before being analyzed.